Keywords
Last Name
Institution

Joshua Zeichner

TitleASSISTANT PROFESSOR
InstitutionMount Sinai
DepartmentDermatology
Address5 East 98th Street, 5th Floor
New York NY 10029
Phone212-241-9728
Fax212-987-1197

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Zeichner JA. Evaluating and treating the adult female patient with acne. J Drugs Dermatol. 2013 Dec 1; 12(12):1416-27.
      View in: PubMed
    2. On SC, Zeichner J. Isotretinoin updates. Dermatol Ther. 2013 Sep-Oct; 26(5):377-89.
      View in: PubMed
    3. Zeichner JA, Bhatt V, Pillai R. In vitro percutaneous absorption of benzoyl peroxide from three fixed combination acne formulations. J Clin Aesthet Dermatol. 2013 Aug; 6(8):19-22.
      View in: PubMed
    4. Gazes MI, Zeichner J. Onychomycosis in close quarter living review of the literature. Mycoses. 2013 Nov; 56(6):610-3.
      View in: PubMed
    5. Zeichner JA, Wong V, Linkner RV, Haddican M. Efficacy and safety of tretinoin 0.025%/clindamycin phosphate 1.2% gel in combination with benzoyl peroxide 6% cleansing cloths for the treatment of facial acne vulgaris. J Drugs Dermatol. 2013 Mar; 12(3):277-82.
      View in: PubMed
    6. Lowenstein EB, Zeichner JA. Intralesional adalimumab for the treatment of refractory balanitis xerotica obliterans. JAMA Dermatol. 2013 Jan; 149(1):23-4.
      View in: PubMed
    7. Levy LL, Zeichner JA. Management of acne scarring, part II: a comparative review of non-laser-based, minimally invasive approaches. Am J Clin Dermatol. 2012 Oct 1; 13(5):331-40.
      View in: PubMed
    8. Zeichner JA, Patel RV, Haddican M, Wong V. Efficacy and safety of a ceramide containing moisturizer followed by fixed-dose clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel in the morning in combination with a ceramide containing moisturizer followed by tretinoin 0.05% gel in the evening for the treatment of facial acne vulgaris. J Drugs Dermatol. 2012 Jun; 11(6):748-52.
      View in: PubMed
    9. Zeichner JA. Considerations when initiating psoriasis patients on biologic therapy. J Drugs Dermatol. 2012 May; 11(5 Suppl):s11-4.
      View in: PubMed
    10. Zeichner JA. Optimizing topical combination therapy for the treatment of acne vulgaris. J Drugs Dermatol. 2012 Mar; 11(3):313-7.
      View in: PubMed
    11. Levy L, Zeichner JA. Dermatologic manifestation of diabetes. J Diabetes. 2012 Mar; 4(1):68-76.
      View in: PubMed
    12. Zeichner JA, Cohen JL. Use of blunt tipped cannulas for soft tissue fillers. J Drugs Dermatol. 2012 Jan; 11(1):70-2.
      View in: PubMed
    13. Zeichner J. Strategies to minimize irritation and potential iatrogenic post-inflammatory pigmentation when treating acne patients with skin of color. J Drugs Dermatol. 2011 Dec; 10(12 Suppl):s25-6.
      View in: PubMed
    14. Zeichner JA, Patel RV, Birge MB. Treatment of Basal cell carcinoma with curettage followed by imiquimod 3.75% cream. J Clin Aesthet Dermatol. 2011 May; 4(5):39-43.
      View in: PubMed
    15. Zeichner JA. Narrowband UV-B phototherapy for the treatment of acne vulgaris during pregnancy. Arch Dermatol. 2011 May; 147(5):537-9.
      View in: PubMed
    16. Frankel AJ, Zeichner JA, Del Rosso JQ. Coal tar 2% foam in combination with a superpotent corticosteroid foam for plaque psoriasis: case report and clinical implications. J Clin Aesthet Dermatol. 2010 Oct; 3(10):42-5.
      View in: PubMed
    17. Zeichner JA, Cohen JL. Dermal fillers in patients on anticoagulants. J Drugs Dermatol. 2010 Sep; 9(9):1059-60.
      View in: PubMed
    18. Zeichner JA, Lebwohl MG, Menter A, Bagel J, Del Rosso JQ, Elewski BE, Feldman SR, Kircik LH, Koo J, Gold LS, Tanghetti E. Optimizing topical therapies for treating psoriasis: a consensus conference. Cutis. 2010 Sep; 86(3 Suppl):5-31; quiz 32.
      View in: PubMed
    19. Zeichner JA. Use of Topical Coal Tar Foam for the Treatment of Psoriasis in Difficult-to-treat Areas. J Clin Aesthet Dermatol. 2010 Sep; 3(9):37-40.
      View in: PubMed
    20. Emer JJ, Frankel A, Zeichner JA. A practical approach to monitoring patients on biological agents for the treatment of psoriasis. J Clin Aesthet Dermatol. 2010 Aug; 3(8):20-6.
      View in: PubMed
    21. Kling M, Zeichner JA. The role of the human papillomavirus (HPV) vaccine in developing countries. Int J Dermatol. 2010 Apr; 49(4):377-9.
      View in: PubMed
    22. Zeichner JA, Stern DW, Uliasz A, Itenberg S, Lebwohl M. Placebo-controlled, double-blind, randomized pilot study of imiquimod 5% cream applied once per week for 6 months for the treatment of actinic keratoses. J Am Acad Dermatol. 2009 Jan; 60(1):59-62.
      View in: PubMed
    23. Uliasz A, Zeichner J, Soung J, Wong V, Lebwohl M. A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatoses. Cutis. 2008 Jun; 81(6):517-9.
      View in: PubMed
    24. Saggar S, Zeichner JA, Brown TT, Phelps RG, Cohen SR. Kaposi's sarcoma resolves after sirolimus therapy in a patient with pemphigus vulgaris. Arch Dermatol. 2008 May; 144(5):654-7.
      View in: PubMed
    25. Breneman D, Fleischer AB, Abramovits W, Zeichner J, Gold MH, Kirsner RS, Shull TF, Crowe AW, Jaracz E, Hanifin JM. Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle. J Am Acad Dermatol. 2008 Jun; 58(6):990-9.
      View in: PubMed
    26. Boguniewicz M, Zeichner JA, Eichenfield LF, Hebert AA, Jarratt M, Lucky AW, Paller AS. MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study. J Pediatr. 2008 Jun; 152(6):854-9.
      View in: PubMed
    27. Zeichner JA, Lebwohl M. Potential complications associated with the use of biologic agents for psoriasis. Dermatol Clin. 2007 Apr; 25(2):207-13, vii.
      View in: PubMed
    28. Halverstam CP, Zeichner J, Lebwohl M. Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature. J Cutan Med Surg. 2006 Nov-Dec; 10(6):291-9.
      View in: PubMed
    29. Zeichner JA, Stern DW, Lebwohl M. Treatment of necrobiosis lipoidica with the tumor necrosis factor antagonist etanercept. J Am Acad Dermatol. 2006 Mar; 54(3 Suppl 2):S120-1.
      View in: PubMed
    30. Hodulik SG, Zeichner JA. Combination therapy with acitretin for psoriasis. J Dermatolog Treat. 2006; 17(2):108-11.
      View in: PubMed
    31. Saavedra WF, Paolocci N, St John ME, Skaf MW, Stewart GC, Xie JS, Harrison RW, Zeichner J, Mudrick D, Marbán E, Kass DA, Hare JM. Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart. Circ Res. 2002 Feb 22; 90(3):297-304.
      View in: PubMed
    32. Zeichner J. Preserving the natural dentition utilizing the root amputation technique. N Y J Dent. 1985 Apr-May; 55(4):129-32.
      View in: PubMed
    33. ZEICHNER J, CHILDRESS WG. Observations on the effect of isoniazid in acute and chronic tuberculous pulmonary lesions. N Y State J Med. 1953 Jun 1; 53(11):1347-57.
      View in: PubMed
    Zeichner's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067